Cargando…
lncRNA MALAT1 participates in metformin inhibiting the proliferation of breast cancer cell
In recent years, the repurposing of conventional and chemotherapeutic drugs is recognized as an alternative strategy for health care. The main purpose of this study is to strengthen the application of non‐oncological drug metformin on breast cancer treatment in the perspective of epigenetics. In the...
Autores principales: | Huang, Yongye, Zhou, Ziyan, Zhang, Jin, Hao, Zhenzhen, He, Yunhao, Wu, Zihan, Song, Yiquan, Yuan, Kexun, Zheng, Shanyu, Zhao, Qi, Li, Tianye, Wang, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335702/ https://www.ncbi.nlm.nih.gov/pubmed/34164906 http://dx.doi.org/10.1111/jcmm.16742 |
Ejemplares similares
-
Modulation of lncRNA H19 enhances resveratrol‐inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress
por: Li, Tianye, et al.
Publicado: (2022) -
LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer
por: Hao, Longhui, et al.
Publicado: (2023) -
BAP31 Regulates Wnt Signaling to Modulate Cell Migration in Lung Cancer
por: Li, Tianye, et al.
Publicado: (2022) -
The role of lncRNA MALAT1 in the regulation of hepatocyte proliferation during liver regeneration
por: Li, Cuicui, et al.
Publicado: (2017) -
Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020)